berberine has been researched along with lactoferrin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, BI | 1 |
| Elkhodairy, KA; Elzoghby, AO; Fang, JY; Helmy, MW; Kabary, DM | 1 |
| Abdelfattah, EA; Elkhodairy, KA; Elzoghby, AO; Fang, JY; Helmy, MW; Kabary, DM | 1 |
| D'Angelo, A; Derosa, G; Di Pierro, F; Maffioli, P | 1 |
2 review(s) available for berberine and lactoferrin
| Article | Year |
|---|---|
Nutritional Management of Metabolic Endotoxemia: A Clinical Review.
Topics: Anti-Infective Agents; Berberine; Diet Therapy; Dysbiosis; Endotoxemia; Fermentation; Glutamine; Humans; Inflammation; Intestinal Mucosa; Lactoferrin; Metabolic Diseases; Permeability; Polyphenols; Prebiotics; Probiotics; Vitamins | 2017 |
Nutraceutical Approach to Preventing Coronavirus Disease 2019 and Related Complications.
Topics: Berberine; China; COVID-19; Dietary Supplements; Fatty Acids, Omega-3; Fungal Polysaccharides; Humans; Lactoferrin; Minerals; Plant Lectins; Polyphenols; SARS-CoV-2; Soy Foods; Vitamins | 2021 |
2 other study(ies) available for berberine and lactoferrin
| Article | Year |
|---|---|
Hyaluronate/lactoferrin layer-by-layer-coated lipid nanocarriers for targeted co-delivery of rapamycin and berberine to lung carcinoma.
Topics: A549 Cells; Animals; Antineoplastic Agents; Berberine; Cell Proliferation; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Humans; Hyaluronic Acid; Lactoferrin; Lipids; Lung Neoplasms; Male; Mice; Nanoparticles; Neoplasms, Experimental; Particle Size; Sirolimus; Surface Properties | 2018 |
Inhalable multi-compartmental phospholipid enveloped lipid core nanocomposites for localized mTOR inhibitor/herbal combined therapy of lung carcinoma.
Topics: A549 Cells; Adenocarcinoma; Administration, Inhalation; Animals; Antineoplastic Combined Chemotherapy Protocols; Berberine; Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Humans; Hyaluronic Acid; Hydrophobic and Hydrophilic Interactions; Lactoferrin; Lung Neoplasms; Male; Mice; Nanocomposites; Phospholipids; Sirolimus | 2018 |